BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 18849352)

  • 1. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
    Marek L; Ware KE; Fritzsche A; Hercule P; Helton WR; Smith JE; McDermott LA; Coldren CD; Nemenoff RA; Merrick DT; Helfrich BA; Bunn PA; Heasley LE
    Mol Pharmacol; 2009 Jan; 75(1):196-207. PubMed ID: 18849352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.
    Terai H; Soejima K; Yasuda H; Nakayama S; Hamamoto J; Arai D; Ishioka K; Ohgino K; Ikemura S; Sato T; Yoda S; Satomi R; Naoki K; Betsuyaku T
    Mol Cancer Res; 2013 Jul; 11(7):759-67. PubMed ID: 23536707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells.
    Marshall ME; Hinz TK; Kono SA; Singleton KR; Bichon B; Ware KE; Marek L; Frederick BA; Raben D; Heasley LE
    Clin Cancer Res; 2011 Aug; 17(15):5016-25. PubMed ID: 21673064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.
    Ware KE; Marshall ME; Heasley LR; Marek L; Hinz TK; Hercule P; Helfrich BA; Doebele RC; Heasley LE
    PLoS One; 2010 Nov; 5(11):e14117. PubMed ID: 21152424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fibroblast growth factor receptor genes in human hepatoma-derived cell lines.
    Asada N; Tanaka Y; Hayashido Y; Toratani S; Kan M; Kitamoto M; Nakanishi T; Kajiyama G; Chayama K; Okamoto T
    In Vitro Cell Dev Biol Anim; 2003; 39(7):321-8. PubMed ID: 14753849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop.
    Ware KE; Hinz TK; Kleczko E; Singleton KR; Marek LA; Helfrich BA; Cummings CT; Graham DK; Astling D; Tan AC; Heasley LE
    Oncogenesis; 2013 Mar; 2(3):e39. PubMed ID: 23552882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Growth Factor Receptor 1 and Related Ligands in Small-Cell Lung Cancer.
    Zhang L; Yu H; Badzio A; Boyle TA; Schildhaus HU; Lu X; Dziadziuszko R; Jassem J; Varella-Garcia M; Heasley LE; Kowalewski AA; Ellison K; Chen G; Zhou C; Hirsch FR
    J Thorac Oncol; 2015 Jul; 10(7):1083-90. PubMed ID: 26020126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.
    Fischer H; Taylor N; Allerstorfer S; Grusch M; Sonvilla G; Holzmann K; Setinek U; Elbling L; Cantonati H; Grasl-Kraupp B; Gauglhofer C; Marian B; Micksche M; Berger W
    Mol Cancer Ther; 2008 Oct; 7(10):3408-19. PubMed ID: 18852144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate.
    Naimi B; Latil A; Fournier G; Mangin P; Cussenot O; Berthon P
    Prostate; 2002 Aug; 52(3):245-52. PubMed ID: 12111699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptors 1 and 2 interact differently with heparin/heparan sulfate. Implications for dynamic assembly of a ternary signaling complex.
    Powell AK; Fernig DG; Turnbull JE
    J Biol Chem; 2002 Aug; 277(32):28554-63. PubMed ID: 12034712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor (FGF)-1, FGF2, FGF7 and FGF receptors are uniformly expressed in trophoblast giant cells during restricted trophoblast invasion in cows.
    Pfarrer C; Weise S; Berisha B; Schams D; Leiser R; Hoffmann B; Schuler G
    Placenta; 2006; 27(6-7):758-70. PubMed ID: 16129484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.
    Ittman M; Mansukhani A
    J Urol; 1997 Jan; 157(1):351-6. PubMed ID: 8976296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of FGF/FGFR pathway blocking on lung adenocarcinoma and its cancer-associated fibroblasts.
    Hegab AE; Ozaki M; Kameyama N; Gao J; Kagawa S; Yasuda H; Soejima K; Yin Y; Guzy RD; Nakamura Y; Ornitz DM; Betsuyaku T
    J Pathol; 2019 Oct; 249(2):193-205. PubMed ID: 31090071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor signaling in non-small-cell lung cancer.
    Semrad TJ; Mack PC
    Clin Lung Cancer; 2012 Mar; 13(2):90-5. PubMed ID: 21959109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells.
    Osada AH; Endo K; Kimura Y; Sakamoto K; Nakamura R; Sakamoto K; Ueki K; Yoshizawa K; Miyazawa K; Saitoh M
    PLoS One; 2019; 14(11):e0217451. PubMed ID: 31682640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF signaling network in the gastrointestinal tract (review).
    Katoh M; Katoh M
    Int J Oncol; 2006 Jul; 29(1):163-8. PubMed ID: 16773196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
    Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
    J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.